diflunisal has been researched along with thromboxane a2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hung, DY; Masci, PP; Mellick, GD; Roberts, MS; Whitaker, AN; Whitehouse, MW | 1 |
1 other study(ies) available for diflunisal and thromboxane a2
Article | Year |
---|---|
Focused antithrombotic therapy: novel anti-platelet salicylates with reduced ulcerogenic potential and higher first-pass detoxification than aspirin in rats.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Aspirin; Blood Platelets; Diflunisal; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Gastric Mucosa; In Vitro Techniques; Inactivation, Metabolic; Liver; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Steroids; Stomach Ulcer; Thromboxane A2 | 1998 |